Inventor · disambiguated record
Tarik Dabdoubi
Also filed as: DABDOUBI TARIK
13 granted patents·10 pending applications·124 citations·filing 2009–2025
91Inventor score
Top patents by PatentIndex Score
23 records- 0195US11530268B2Trispecific anti-CD38, anti-CD28, and anti-CD3 binding proteins and methods of use for treating viral infectionSANOFI SA·Filed 2019·Granted Dec 20, 2022·15 cites·34 claims
- 0295US11365261B2Anti-CD38 antibodies and methods of useSANOFI SA·Filed 2021·Granted Jun 21, 2022·3 cites·29 claims
- 0395US9617345B2Anti-CEACAM5 antibodies and uses thereofSANOFI SA·Filed 2015·Granted Apr 11, 2017·53 cites·20 claims
- 0494US11613576B2Trispecific binding proteins, methods, and uses thereofSANOFI SA·Filed 2020·Granted Mar 28, 2023·3 cites·29 claims
- 0594US11186649B2Anti-CD38 antibodies and methods of useSANOFI SA·Filed 2018·Granted Nov 30, 2021·10 cites·41 claims
- 0691US11332542B2Anti-CEACAM5 antibodies and uses thereofSANOFI SA·Filed 2019·Granted May 17, 2022·4 cites·11 claims
- 0787US10457739B2Anti-CEACAM5 antibodies and uses thereofSANOFI SA·Filed 2017·Granted Oct 29, 2019·6 cites·40 claims
- 0887US9493529B2Robo1-Fc fusion protein and use thereof for treating tumoursBLANCHE FRANCIS·Filed 2011·Granted Nov 15, 2016·20 cites·11 claims
- 0983US8852593B2Antagonist antibodies and their fab fragments against GPVI and uses thereofBAURIN NICOLAS·Filed 2010·Granted Oct 7, 2014·8 cites·8 claims
- 1082US12227573B2Trispecific binding proteins, methods, and uses thereofSANOFI SA·Filed 2023·Granted Feb 18, 2025·0 cites·45 claims
- 1172US2023357401A1Trispecific anti-cd38, anti-cd28, and anti-cd3 binding proteins and methods of use for treating viral infectionSANOFI SA·Filed 2022·Application pending·0 cites
- 1272US2022275102A1Anti-cd38 antibodies and methods of useSANOFI SA·Filed 2022·Application pending·0 cites
- 1371US2025250337A1Trispecific binding proteins, methods, and uses thereofSANOFI SA·Filed 2025·Application pending·0 cites
- 1463US2024226314A1Transferrin receptor binding proteinsSANOFI SA·Filed 2023·Application pending·0 cites
- 1562US9809653B2Anti-LAMP1 antibodies and antibody drug conjugates, and uses thereofSANOFI SA·Filed 2015·Granted Nov 7, 2017·1 cites·17 claims
- 1662US2024262923A1Anti-pd-1×4-1bb binding proteinsGENZYME CORP·Filed 2023·Application pending·0 cites
- 1760US9234039B2Peptide or peptide complex binding to ALPHA2 integrin and methods and uses involving the sameCORVEY CARSTEN·Filed 2011·Granted Jan 12, 2016·1 cites·17 claims
- 1857US9441040B2Antagonist antibodies and their fab fragments against GPVI and uses thereofSANOFI SA·Filed 2014·Granted Sep 13, 2016·0 cites·15 claims
- 1950US2011150903A1Fgf-r4 receptor-specific antagonistsSANOFI AVENTIS·Filed 2009·Application pending·0 cites
- 2041US2013108641A1Anti-gitr antibodiesBAURIN NICOLAS·Filed 2012·Application pending·0 cites
- 2140US2016176970A1Peptide or peptide complex binding to alpha2 integrin and methods and uses involving the sameSANOFI SA·Filed 2015·Application pending·0 cites
- 2239US2018142032A1Anti-lamp1 antibodies and antibody drug conjugates, and uses thereofSANOFI SA·Filed 2017·Application pending·0 cites
- 2332US2012282637A1Polypeptides for binding to the receptor for advanced glycation endproducts as well as compositions and methods involvingHUBER JOCHEN·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Tarik Dabdoubi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →